August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

Educational, Digital, Campaign Tools Cut Antibiotic Use

Antibiotic prescribing for common respiratory tract infections was more frequent in urgent care than in primary care, with patterns shaped by patient age and diagnosis.

Conexiant

August 26, 2025

Rituximab Linked to Weakened COVID-19 Immunity

Rituximab-treated patients with rheumatic disease had diminished antibody levels and impaired CD8+ T-cell responses after SARS-CoV-2 infection and vaccination, though CD4+ responses remained intact.

Conexiant

August 26, 2025

COVID-19 May Accelerate Vascular Aging

COVID-19 survivors demonstrate persistent endothelial dysfunction that is consistent with premature vascular aging of up to 7.5 years.

Conexiant

August 26, 2025

Can States Still Respond to Outbreaks?

Following court injunctions, some states and cities regained funding, while others experienced continued cancellations that affected immunization clinics, workforce capacity, and infectious-disease surveillance.

KFF Health News

August 25, 2025

What Does Xlear’s Lawsuit Mean for Physicians?

Xlear's xylitol maker sues the FTC to loosen evidence rules on health claims, signaling a deregulatory push that could reshape supplement marketing.

KFF Health News

August 22, 2025

New CT Score Tracks Pneumonia Stage Progression

Researchers validate a visual CT scoring system designed to improve classification of pneumonia-related lung changes in clinical and research settings.

Conexiant

August 22, 2025

Outcomes Associated With COVID-19 Infection in Patients With Cancer

“The results of this prospective cohort study showed that COVID-19 had a significant impact on patients with cancer, including hospitalization, treatment disruptions, and death.”

The ASCO Post

August 19, 2025

‘Enough Is Enough’—But When?

How Bogalusa, Louisiana became a lens on the US gun violence epidemic—where race, poverty, policy, and profit converge and communities bear the cost.

KFF Health News